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Letters to the
Editor
Limitations on the role of vacuum-
assisted closure in cardiac surgery
To the Editor:
We disagree with the conclusion of the
article of Luckraz and colleagues1 that vac-
uum-assisted closure (VAC) “can be used
alone as acceptable treatment modality for
sternal wound infection.” In their series of
27 patients with postoperative mediastini-
tis, the intended treatment was VAC ini-
tially, but only 14 patients actually had
VAC only (group A), whereas the other 13
patients had VAC followed by myocutane-
ous flap. Of the latter group, 8 patients
underwent flap closure because “the wound
was clean and granulating but too large,”
and 5 more underwent direct closure “be-
cause this facilitated discharge from hospi-
tal.”1 This represents a gross 50% failure of
the original intended treatment and invali-
dates the group’s conclusions.
Moreover, of the 14 patients in group A
who had VAC only, only 8 had de´bride-
ment of the sternum, whereas 6 did not. It
is not said how many patients who died in
groups A and B did not have de´bridement.
In group A, 4 patients died (28.6%), and
only 64% survived with healed scar. This
in our opinion, does not represent a suc-
cessful result of the VAC-only therapeutic
modality.
Furthermore, 2 patients in group A had
multiple organ failure. It was not said
whether these 2 patients had persistent me-
diastinitis. Did they have de´bridement of
the sternum?
We also believe that the incidence of
mediastinitis among the patients was mis-
calculated by the authors, because 27 of
491 patients would be 5%, not 0.05% as
stated, and in our opinion represents a rate
higher than expected from reports in the
literature. The incidence of mediastinitis
before VAC was also miscalculated, be-
cause 13 of 310 is 4%, not 0.04% as stated.
On the basis of these data, we conclude
that VAC alone was successful in a few
selected cases and cannot be recommended
as solitary treatment. We believe that de´-
bridement of the sternum and mediastinum
is an obligatory procedure for every patient
who has a deep sternal wound. Often there
is accumulation of infected fibrin that
needs to be completely removed, and a few
patients have fragments of sternum that are
devascularized and need to be excised to
promote granulation and healing. We favor
omental flaps rather than myocutaneous
flaps after the de´bridement, because they
are easy, quick, and successful in taking
care of the deep mediastinal infection in
100% of the cases. The procedure can be
done by the cardiac surgeon and also al-
lows closure of the sternum, which is suc-
cessful in about 80% of the cases.
We support the use of the VAC when
the sternum redehisces after initial de´bride-
ment and closure, or when the sternum
needs to be removed because of devascu-
larization. VAC is also helpful when the
subcutaneous tissue does not heal after ini-
tial de´bridement, omental flap, and closure.
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Reply to the Editor:
We note the comments of Aru and Call.
Our article1 described our initial experi-
ence with vacuum-assisted closure (VAC)
for treating sternal wound infection. It was
a purely descriptive rather than compara-
tive process, and hence the results should
be interpreted likewise. The number of pa-
tients described was relatively small (27
patients), and sweeping conclusions may
be misleading. However, in the population
group that we described, VAC represented
an acceptable treatment option relative to
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